Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

Directly Administered Antiretroviral Therapy (DAART) Among HIV-1infected Injecting Drug Users (IDUs) in Chennai, India

Phase 2

Withdrawn

Conditions: HIV Infections
Heroin Dependence

Interventions: Behavioral: Directly Administered Antiretroviral Therapy (DAART)
Behavioral: SAT

First Posted Date: 2008-07-03

Last Posted Date: 2015-04-15

Lead Sponsor: Johns Hopkins University

Registration Number: NCT00709007

Locations: 🇮🇳
YR Gaitonde Centre for Substance Abuse-Related Research (YRGCSAR), Chennai, Tamil Nadu, India

Effect of Vitamin A in the Treatment of Neonatal Sepsis and Necrotizing Enterocolitis

Phase 3

Completed

Conditions: Sepsis
Necrotizing Enterocolitis
Pneumonia
Meningitis

Interventions: Dietary Supplement: Vitamin A

First Posted Date: 2008-07-01

Last Posted Date: 2013-09-25

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 424

Registration Number: NCT00707785

Locations: 🇧🇩
Dhaka Shishu Hospital, Dhaka, Bangladesh

Enema Use and Acceptability in HIV Negative Men Who Have Sex With Men

Not Applicable

Completed

Conditions: HIV Infections

Interventions: Drug: Fleet Enema
Drug: tap water enema
Drug: Normosol-R enema

First Posted Date: 2008-06-13

Last Posted Date: 2017-04-28

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 9

Registration Number: NCT00696618

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Using Magnetic Resonance Imaging to Evaluate Heart Vessel Function After Angioplasty or Stent Placement Procedures

Completed

Conditions: Angina, Unstable
Cardiomyopathy, Hypertrophic
Myocardial Infarction

First Posted Date: 2008-06-06

Last Posted Date: 2016-02-23

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 144

Registration Number: NCT00692991

Locations: 🇺🇸
Johns Hopkins Medical Institution, Baltimore, Maryland, United States

The Effect of Surgically Induced Weight Loss on Endocrine Function, Cardiovascular Function and Body Composition

Phase 2

Terminated

Conditions: Bariatric Surgery

Interventions: Drug: GLP-1

First Posted Date: 2008-05-30

Last Posted Date: 2017-07-02

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 51

Registration Number: NCT00686972

Locations: 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

Clinical Trial of Topiramate for Cocaine Addiction

Phase 2

Completed

Conditions: Cocaine Dependence

Interventions: Drug: topiramate
Drug: placebo + NonCR
Behavioral: Contingency Reinforcement

First Posted Date: 2008-05-28

Last Posted Date: 2017-07-11

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 250

Registration Number: NCT00685178

Locations: 🇺🇸
Behavioral Pharmacology Research Unit, Baltimore, Maryland, United States

Employment-Based Depot Naltrexone Clinical Trial

Phase 2

Completed

Conditions: Opiate Dependence

Interventions: Combination Product: employment-based reinforcement

First Posted Date: 2008-05-28

Last Posted Date: 2017-12-26

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 35

Registration Number: NCT00684788

Locations: 🇺🇸
The Center for Learning and Health, Baltimore, Maryland, United States

Employment-Based Depot Naltrexone Clinical Trial II

Phase 2

Completed

Conditions: Opiate Dependence

Interventions: Combination Product: Work Plus Naltrexone Contingency

First Posted Date: 2008-05-28

Last Posted Date: 2018-01-23

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 38

Registration Number: NCT00684775

Locations: 🇺🇸
The Center for Learning and Health, Baltimore, Maryland, United States

Atkins Plus KetoCal for Childhood Epilepsy

Phase 3

Completed

Conditions: Epilepsy

Interventions: Dietary Supplement: Modified Atkins diet and KetoCal

First Posted Date: 2008-05-21

Last Posted Date: 2009-12-31

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 30

Registration Number: NCT00681239

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Combined aPproach to Treatment Using Ranibizumab and Efalizumab for Diabetic Macular Edema Study: The CAPTURE DME Study

Phase 1

Withdrawn

Conditions: Diabetic Macular Edema

Interventions: Drug: Efalizumab
Drug: Ranibizumab

First Posted Date: 2008-05-13

Last Posted Date: 2016-08-26

Lead Sponsor: Johns Hopkins University

Registration Number: NCT00676559

Locations: 🇺🇸
Sharp Rees-Stealy Medical Group, San Diego, California, United States
🇺🇸
Ophthalmic Consultants of Boston, Boston, Massachusetts, United States
🇺🇸
Eye Care Specialists, Kingston, Pennsylvania, United States

and more 7 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy